Description
- Hepatitis B virus nucleoside reverse transcriptase inhibitors
- Effective in Lamividine resistance cases
- High genetic barrier to resistance of HBV
- Excellent resistance profile
Dosage-
Take it on an empty stomach, at least 2 hours after or before a meal.
• Nucleoside inhibitor treatment-naive with compensated liver disease (adults and adolescents > 16 yr): 0.5 mg OD
Lamivudine-refractory or known lamivudine or telbivudine resistance substitutions (adults and adolescents > 16 yr): 1 mg OD
Reviews
There are no reviews yet.